Skip to main content
Erschienen in: Diabetologia 10/2006

01.10.2006 | Article

End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry

verfasst von: X. L. Yang, W. Y. So, A. P. S. Kong, P. Clarke, C. S. Ho, C. W. K. Lam, M. H. L. Ng, R. R. Lyu, D. D. Yin, C. C. Chow, C. S. Cockram, P. C. Y. Tong, J. C. N. Chan

Erschienen in: Diabetologia | Ausgabe 10/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The objective of the study was to investigate risk factors and develop risk equations for end-stage renal disease (ESRD) in Chinese patients with type 2 diabetes.

Subjects and methods

A prospective cohort of 4,438 patients with type 2 diabetes mellitus and without ESRD (median observation period 2.9 years, interquartile range 1.6–4.1 years) was included in the analysis. The end-point (ESRD) was defined by: (1) death due to diabetes with renal manifestations or renal failure; (2) hospitalisation due to renal failure; (3) estimated GFR (eGFR) <15 ml min−1 1.73 m−2. Cox proportional hazards regression was used to develop risk equations. The data were randomly and evenly divided into the training data for development of the risk equations and the test data for validation. The validation was performed using the area under the receiver operating characteristic curve (aROC), which takes into account follow-up time and censoring.

Results

During the observation period, 159 patients or 12.45 per 1,000 person-years (95% CI 10.52–14.37 per 1,000 person-years) developed ESRD. Known duration of diabetes, systolic blood pressure, log10 total cholesterol:HDL cholesterol ratio and retinopathy were significant predictors of ESRD. After further adjusting for eGFR, log10 spot albumin:creatinine ratio (ACR) and haematocrit, only eGFR, haematocrit and log10 ACR remained as independent predictors of ESRD. The risk equation derived from these three independent predictors had good discrimination, with an aROC of 0.97.

Conclusions/interpretation

Estimated GFR, haematocrit and ACR were independent predictors of ESRD and the derived risk equation performed well in Chinese patients with type 2 diabetes.
Literatur
1.
Zurück zum Zitat Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787PubMedCrossRef Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787PubMedCrossRef
2.
Zurück zum Zitat Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMedCrossRef Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMedCrossRef
3.
Zurück zum Zitat Pan XR, Yang WY, Li GW, Liu J (1997) Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 20:1664–1669PubMedCrossRef Pan XR, Yang WY, Li GW, Liu J (1997) Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 20:1664–1669PubMedCrossRef
4.
Zurück zum Zitat Ritz E, Rychlik I, Locatelli F, Halimi S (1999) End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 34:795–808PubMed Ritz E, Rychlik I, Locatelli F, Halimi S (1999) End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 34:795–808PubMed
5.
Zurück zum Zitat Wu AY, Kong NC, de Leon FA et al (2005) An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 48:17–26PubMedCrossRef Wu AY, Kong NC, de Leon FA et al (2005) An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 48:17–26PubMedCrossRef
6.
Zurück zum Zitat Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV (2002) Ethnic disparities in diabetic complications in an insured population. JAMA 287:2519–2527PubMedCrossRef Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV (2002) Ethnic disparities in diabetic complications in an insured population. JAMA 287:2519–2527PubMedCrossRef
7.
Zurück zum Zitat Stevens RJ, Kothari V, Adler AI, Stratton IM (2001) The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 101:671–679CrossRef Stevens RJ, Kothari V, Adler AI, Stratton IM (2001) The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 101:671–679CrossRef
8.
Zurück zum Zitat Kothari V, Stevens RJ, Adler AI et al (2002) UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 33:1776–1781PubMedCrossRef Kothari V, Stevens RJ, Adler AI et al (2002) UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 33:1776–1781PubMedCrossRef
9.
Zurück zum Zitat British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society (1998) Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association. Heart 80(Suppl 2):S1–S29 British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society (1998) Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association. Heart 80(Suppl 2):S1–S29
10.
Zurück zum Zitat National Cholesterol Education Program (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef National Cholesterol Education Program (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef
11.
Zurück zum Zitat Clarke PM, Gray AM, Briggs A et al (2004) A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) outcomes model (UKPDS No. 68). Diabetologia 47:1747–1759PubMedCrossRef Clarke PM, Gray AM, Briggs A et al (2004) A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) outcomes model (UKPDS No. 68). Diabetologia 47:1747–1759PubMedCrossRef
12.
Zurück zum Zitat Hall YN, Hsu CY, Iribarren C, Darbinian J, McCulloch CE, Go AS (2005) The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int 68:2310–2316PubMedCrossRef Hall YN, Hsu CY, Iribarren C, Darbinian J, McCulloch CE, Go AS (2005) The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int 68:2310–2316PubMedCrossRef
13.
Zurück zum Zitat Leung WY, So WY, Tong PC, Chan NN, Chan JC (2005) Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy. Am J Med 118:1414PubMedCrossRef Leung WY, So WY, Tong PC, Chan NN, Chan JC (2005) Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy. Am J Med 118:1414PubMedCrossRef
14.
Zurück zum Zitat Kong AP, So WY, Szeto CC et al (2006) Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes. Kidney Int 69:383–387PubMedCrossRef Kong AP, So WY, Szeto CC et al (2006) Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes. Kidney Int 69:383–387PubMedCrossRef
15.
Zurück zum Zitat Tong PC, Lee KF, So WY et al (2004) White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care 27:216–222PubMedCrossRef Tong PC, Lee KF, So WY et al (2004) White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care 27:216–222PubMedCrossRef
16.
Zurück zum Zitat Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M (1993) For the DIABCARE Monitoring Group of the St. Vincent Declaration Steering Committee. Monitoring the targets of the St. Vincent declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. Diabetic Med 10:371–377PubMed Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M (1993) For the DIABCARE Monitoring Group of the St. Vincent Declaration Steering Committee. Monitoring the targets of the St. Vincent declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. Diabetic Med 10:371–377PubMed
18.
Zurück zum Zitat National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266CrossRef National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266CrossRef
19.
Zurück zum Zitat So WY, Ozaki R, Chan NN et al (2004) Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients. Hypertension 44:294–299PubMedCrossRef So WY, Ozaki R, Chan NN et al (2004) Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients. Hypertension 44:294–299PubMedCrossRef
20.
Zurück zum Zitat Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed
21.
Zurück zum Zitat Colhoun HM, Lee ET, Bennett PH et al (2001) Risk factors for renal failure: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl 2):S46–S53PubMedCrossRef Colhoun HM, Lee ET, Bennett PH et al (2001) Risk factors for renal failure: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl 2):S46–S53PubMedCrossRef
22.
Zurück zum Zitat Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36PubMed Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36PubMed
23.
Zurück zum Zitat Chambless LE, Diao G (2005) Estimation of time-dependent area under the ROC curve for long-term risk prediction. Stat Med (Epub ahead of print). DOI 10.1002/sim.2299 Chambless LE, Diao G (2005) Estimation of time-dependent area under the ROC curve for long-term risk prediction. Stat Med (Epub ahead of print). DOI 10.​1002/​sim.​2299
24.
Zurück zum Zitat Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18:695–706PubMedCrossRef Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18:695–706PubMedCrossRef
25.
Zurück zum Zitat Orford JL, Sesso HD, Stedman M, Gagnon D, Vokonas P, Gaziano JM (2002) A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. Am Heart J 144:95–100PubMedCrossRef Orford JL, Sesso HD, Stedman M, Gagnon D, Vokonas P, Gaziano JM (2002) A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. Am Heart J 144:95–100PubMedCrossRef
26.
Zurück zum Zitat Liu J, Hong Y, D’Agostino RB Sr et al (2004) Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 291:2591–2599PubMedCrossRef Liu J, Hong Y, D’Agostino RB Sr et al (2004) Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 291:2591–2599PubMedCrossRef
27.
Zurück zum Zitat Guzder RN, Gatling W, Mullee MA, Mehta RL, Byrne CD (2005) Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed type 2 diabetes: results from a United Kingdom Study. Diabet Med 22:554–562PubMedCrossRef Guzder RN, Gatling W, Mullee MA, Mehta RL, Byrne CD (2005) Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed type 2 diabetes: results from a United Kingdom Study. Diabet Med 22:554–562PubMedCrossRef
28.
Zurück zum Zitat Keane WF, Brenner BM, de Zeeuw D et al (2003) The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL Study. Kidney Int 63:1499–1507PubMedCrossRef Keane WF, Brenner BM, de Zeeuw D et al (2003) The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL Study. Kidney Int 63:1499–1507PubMedCrossRef
29.
Zurück zum Zitat Stephenson JM, Kenny S, Stevens LK, Fuller JH, Lee E (1995) Proteinuria and mortality in diabetes: the WHO Multinational Study of Vascular Disease in Diabetes. Diabet Med 12:149–155PubMedCrossRef Stephenson JM, Kenny S, Stevens LK, Fuller JH, Lee E (1995) Proteinuria and mortality in diabetes: the WHO Multinational Study of Vascular Disease in Diabetes. Diabet Med 12:149–155PubMedCrossRef
30.
Zurück zum Zitat de Zeeuw D, Remuzzi G, Parving HH et al (2004) Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110:921–927PubMedCrossRef de Zeeuw D, Remuzzi G, Parving HH et al (2004) Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110:921–927PubMedCrossRef
31.
Zurück zum Zitat Chan JC, Cheung CK, Cheung MY, Swaminathan R, Critchley JA, Cockram CS (1995) Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM. Diabetes Care 18:1013–1016PubMedCrossRef Chan JC, Cheung CK, Cheung MY, Swaminathan R, Critchley JA, Cockram CS (1995) Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM. Diabetes Care 18:1013–1016PubMedCrossRef
32.
Zurück zum Zitat Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32:219–226PubMedCrossRef Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32:219–226PubMedCrossRef
33.
Zurück zum Zitat Bakris GL (1996) Microalbuminuria: prognostic implications. Curr Opin Nephrol Hypertens 5:219–223PubMedCrossRef Bakris GL (1996) Microalbuminuria: prognostic implications. Curr Opin Nephrol Hypertens 5:219–223PubMedCrossRef
34.
Zurück zum Zitat Bakris GL, Williams M, Dworkin L et al (2000) Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36:646–661PubMed Bakris GL, Williams M, Dworkin L et al (2000) Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36:646–661PubMed
35.
Zurück zum Zitat Cooper ME (1998) Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 352:213–219PubMedCrossRef Cooper ME (1998) Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 352:213–219PubMedCrossRef
36.
Zurück zum Zitat Manttari M, Tiula E, Alikoski T, Manninen V (1995) Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 26:670–675PubMed Manttari M, Tiula E, Alikoski T, Manninen V (1995) Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 26:670–675PubMed
37.
Zurück zum Zitat Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ (2000) Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58:293–301PubMedCrossRef Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ (2000) Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58:293–301PubMedCrossRef
38.
Zurück zum Zitat Hackam DG (2005) Cardiovascular risk prevention in peripheral artery disease. J Vasc Surg 41:1070–1073PubMedCrossRef Hackam DG (2005) Cardiovascular risk prevention in peripheral artery disease. J Vasc Surg 41:1070–1073PubMedCrossRef
39.
Zurück zum Zitat Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC (2003) Peripheral vascular disease in type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors. Diabet Med 20:988–995PubMedCrossRef Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC (2003) Peripheral vascular disease in type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors. Diabet Med 20:988–995PubMedCrossRef
40.
Zurück zum Zitat Chan JC, Wat NM, So WY et al (2004) Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study. Diabetes Care 27:874–879PubMedCrossRef Chan JC, Wat NM, So WY et al (2004) Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study. Diabetes Care 27:874–879PubMedCrossRef
41.
Zurück zum Zitat Broom J (2002) Anaemia in diabetic renal disease: an underestimated risk factor. Acta Diabetol 39(Suppl 1):S2PubMedCrossRef Broom J (2002) Anaemia in diabetic renal disease: an underestimated risk factor. Acta Diabetol 39(Suppl 1):S2PubMedCrossRef
42.
Zurück zum Zitat Ueda H, Ishimura E, Shoji T et al (2003) Factors affecting progression of renal failure in patients with type 2 diabetes. Diabetes Care 26:1530–1534PubMedCrossRef Ueda H, Ishimura E, Shoji T et al (2003) Factors affecting progression of renal failure in patients with type 2 diabetes. Diabetes Care 26:1530–1534PubMedCrossRef
43.
Zurück zum Zitat Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53–61PubMed Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53–61PubMed
44.
Zurück zum Zitat Ishimura E, Nishizawa Y, Okuno S et al (1998) Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. J Nephrol 11:83–86PubMed Ishimura E, Nishizawa Y, Okuno S et al (1998) Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. J Nephrol 11:83–86PubMed
45.
Zurück zum Zitat Dean BB, Dylan M, Gano A Jr, Knight K, Ofman JJ, Levine BS (2005) Erythropoiesis-stimulating protein therapy and the decline of renal function: a retrospective analysis of patients with chronic kidney disease. Curr Med Res Opin 21:981–987PubMedCrossRef Dean BB, Dylan M, Gano A Jr, Knight K, Ofman JJ, Levine BS (2005) Erythropoiesis-stimulating protein therapy and the decline of renal function: a retrospective analysis of patients with chronic kidney disease. Curr Med Res Opin 21:981–987PubMedCrossRef
46.
Zurück zum Zitat Chuahirun T, Simoni J, Hudson C et al (2004) Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci 327:57–67PubMedCrossRef Chuahirun T, Simoni J, Hudson C et al (2004) Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci 327:57–67PubMedCrossRef
47.
Zurück zum Zitat Parving HH, Tarnow L, Rossing P (1996) Genetics of diabetic nephropathy. J Am Soc Nephrol 7:2509–2517PubMed Parving HH, Tarnow L, Rossing P (1996) Genetics of diabetic nephropathy. J Am Soc Nephrol 7:2509–2517PubMed
48.
Zurück zum Zitat Casas JP, Chua W, Loukogeorgakis S et al (2005) Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 366:2026–2033PubMedCrossRef Casas JP, Chua W, Loukogeorgakis S et al (2005) Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 366:2026–2033PubMedCrossRef
49.
Zurück zum Zitat Pintilie M (2002) Dealing with competing risks: testing covariates and calculating sample size. Stat Med 21:3317–3324PubMedCrossRef Pintilie M (2002) Dealing with competing risks: testing covariates and calculating sample size. Stat Med 21:3317–3324PubMedCrossRef
50.
Zurück zum Zitat Andersen PK, Abildstrom SZ, Rosthoj S (2002) Competing risks as a multi-state model. Stat Methods Med Res 11:203–215PubMedCrossRef Andersen PK, Abildstrom SZ, Rosthoj S (2002) Competing risks as a multi-state model. Stat Methods Med Res 11:203–215PubMedCrossRef
51.
Zurück zum Zitat Zuo L, Ma YC, Zhou YH, Wang M, Xu GB, Wang HY (2005) Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis 45:463–472PubMedCrossRef Zuo L, Ma YC, Zhou YH, Wang M, Xu GB, Wang HY (2005) Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis 45:463–472PubMedCrossRef
Metadaten
Titel
End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry
verfasst von
X. L. Yang
W. Y. So
A. P. S. Kong
P. Clarke
C. S. Ho
C. W. K. Lam
M. H. L. Ng
R. R. Lyu
D. D. Yin
C. C. Chow
C. S. Cockram
P. C. Y. Tong
J. C. N. Chan
Publikationsdatum
01.10.2006
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 10/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0376-3

Weitere Artikel der Ausgabe 10/2006

Diabetologia 10/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.